Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor.

Echchgadda I, Song CS, Roy AK, Chatterjee B.

Mol Pharmacol. 2004 Mar;65(3):720-9.

2.

Gene regulation for the senescence marker protein DHEA-sulfotransferase by the xenobiotic-activated nuclear pregnane X receptor (PXR).

Echchgadda I, Song CS, Oh TS, Cho SH, Rivera OJ, Chatterjee B.

Mech Ageing Dev. 2004 Oct-Nov;125(10-11):733-45.

PMID:
15541768
3.

Vitamin D receptor regulation of the steroid/bile acid sulfotransferase SULT2A1.

Chatterjee B, Echchgadda I, Song CS.

Methods Enzymol. 2005;400:165-91. Review.

PMID:
16399349
4.

An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1).

Song CS, Echchgadda I, Seo YK, Oh T, Kim S, Kim SA, Cho S, Shi L, Chatterjee B.

Mol Endocrinol. 2006 Apr;20(4):795-808. Epub 2005 Dec 15. Erratum in: Mol Endocrinol. 2006 Jun;20(6):1286.

PMID:
16357103
5.

Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor.

Song CS, Echchgadda I, Baek BS, Ahn SC, Oh T, Roy AK, Chatterjee B.

J Biol Chem. 2001 Nov 9;276(45):42549-56. Epub 2001 Aug 30.

6.

Regulation of sulfotransferases by xenobiotic receptors.

Runge-Morris M, Kocarek TA.

Curr Drug Metab. 2005 Aug;6(4):299-307. Review.

PMID:
16101570
7.
8.

Nuclear receptor interactions in methotrexate induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1).

Chen X, Maiti S, Zhang J, Chen G.

J Biochem Mol Toxicol. 2006;20(6):309-17.

PMID:
17163485
9.

Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.

Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E.

Mol Pharmacol. 2001 Dec;60(6):1399-406.

10.

Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response.

Kim MS, Shigenaga J, Moser A, Grunfeld C, Feingold KR.

Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E731-8. Epub 2004 Jun 15.

11.

Induction of phase I, II and III drug metabolism/transport by xenobiotics.

Xu C, Li CY, Kong AN.

Arch Pharm Res. 2005 Mar;28(3):249-68. Review.

PMID:
15832810
12.

Intestinal cell-specific vitamin D receptor (VDR)-mediated transcriptional regulation of CYP3A4 gene.

Pavek P, Pospechova K, Svecova L, Syrova Z, Stejskalova L, Blazkova J, Dvorak Z, Blahos J.

Biochem Pharmacol. 2010 Jan 15;79(2):277-87. doi: 10.1016/j.bcp.2009.08.017. Epub 2009 Aug 25.

PMID:
19712670
13.

Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor.

Fang HL, Strom SC, Cai H, Falany CN, Kocarek TA, Runge-Morris M.

Mol Pharmacol. 2005 Apr;67(4):1257-67. Epub 2005 Jan 5.

14.
15.
16.

Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver.

Khan AA, Chow EC, van Loenen-Weemaes AM, Porte RJ, Pang KS, Groothuis GM.

Eur J Pharm Sci. 2009 May 12;37(2):115-25. doi: 10.1016/j.ejps.2009.01.006. Epub 2009 Jan 30.

PMID:
19429418
17.

Two nuclear signalling pathways for vitamin D.

Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF, Hunziker W.

Nature. 1993 Feb 18;361(6413):657-60.

PMID:
8382345
18.

Pregnane X receptor is a target of farnesoid X receptor.

Jung D, Mangelsdorf DJ, Meyer UA.

J Biol Chem. 2006 Jul 14;281(28):19081-91. Epub 2006 May 8.

19.

Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.

Jurutka PW, Thompson PD, Whitfield GK, Eichhorst KR, Hall N, Dominguez CE, Hsieh JC, Haussler CA, Haussler MR.

J Cell Biochem. 2005 Apr 1;94(5):917-43.

PMID:
15578590

Supplemental Content

Support Center